CNTB Connect Biopharma Holdings Year-over-year net earnings per share growth for the last 12 months
Connect Biopharma is revising its business model, shifting toward global licensing of immunological developments to minimize R&D costs. The company has earned the trust of dermatologists by creating effective treatments for severe allergies. Historical quarterly EPS growth demonstrates profit dynamics, where -18.30 expresses the latest level of the metric. This confirms the strategy to scale the T-cell pipeline for expansion within the immunopharmaceuticals sector.
Analytical breakdowns and data insights for company Connect Biopharma (CNTB)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital Connect Biopharma|CNTB - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity connectbiopharm.com|CNTB - Company Cumulative Debt|Debt to Book Capitalization Ratio Connect Pharma|CNTB - Company Long-Term Indebtedness|Company Short-Term Debt Connect Biopharma|Quick Ratio connectbiopharm.com
- earnings and market multiples details:
CNTB - Company Net Income|Projected Future Earnings Connect Biopharma|CNTB - Price to Earnings Ratio|Projected Price to Earnings connectbiopharm.com|CNTB - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio Connect Pharma|CNTB - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Connect Biopharma|CNTB - Earnings per share for the last twelve months|Quarterly EPS earnings growth connectbiopharm.com|CNTB - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Connect Biopharma
Comprehensive company analysis:Connect Biopharma
This indicator measures the operational change in earnings per share on a quarterly basis, allowing for the identification of hidden financial risks and the probability of overpaying for the asset. By analyzing the quarterly earnings per share trend, an investor assesses the capital stability of Connect Biopharma (CNTB), whose production outsourcing model to CDMO bio-factories minimizes capital expenditures and the impact of equipment downtime.
Key competitors
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Corp - Quarterly EPS earnings growth|Celldex Corp (CLDX) - Year-over-year net earnings per share growth for the last 12 months|Aurinia Pharmaceuticals (AUPH) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months biocryst.com (BCRX)|Year-over-year earnings per share growth for the last twelve months Vera Therapeutics|Year-over-year earnings per share growth for the last 12 months DNTH (Dianthus Therapeutics Inc)|Year-over-year earnings per share growth for the last twelve months Pharvaris Corp (PHVS)|AbCellera Bio - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth TRML (Tourmaline Bio, Inc.)|precigen.com (PGEN) - Earnings per share growth in annualized terms for the last twelve months|Pharming Group - Quarterly EPS earnings growth|Nektar Therapeutics Inc (NKTR) - Year-over-year net earnings per share growth for the last 12 months|UPB (Upstream Bio Corp) - Year-over-year net earnings per share growth for the last 12 months|ZBIO: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months IMNM|GOSS: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth KALV|Year-over-year earnings per share growth for the last twelve months SEPN (Septerna, Inc.)|Quarterly EPS earnings growth PVLA (Pieris Pharmaceuticals Inc)|Year-over-year net earnings per share change for the last twelve months Savara Pharma (SVRA)|RIGL - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months anaptysbio.com|Astria Therapeutics, Inc. (ATXS) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ENGN (enGene Holdings Inc)|RAPT (RAPT Therapeutics) - Quarterly EPS earnings growth|JBIO: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACRS|Quarterly EPS earnings growth kyvernatx.com (KYTX)|Year-over-year earnings per share growth for the last twelve months Tiziana Life Sciences Ltd TLSA|Year-over-year earnings per one share growth for the last 12 months CABA|VTYX - Year-over-year earnings per share growth for the last twelve months|Theratechnologies, Inc (THTX) - Year-over-year net earnings per share growth for the last 12 months|AVTX: Quarterly EPS earnings growth|eledon.com (ELDN) - Quarterly EPS earnings growth|AGEN (Agenus Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Climb Bio Inc. (CLYM)|Year-over-year earnings per share growth for the last twelve months Zura Bio (ZURA)|aTyr Pharmaceuticals - Year-over-year earnings per share growth for the last 12 months|Adagene Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months IMA (ImageneBio)|Shattuck Therapeutics - Quarterly EPS earnings growth|EQ: Year-over-year earnings per share growth for the last twelve months|immunic-therapeutics.com (IMUX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ATRA (Atara Bio)|IFRX (InflaRx NV) - Quarterly EPS earnings growth|XFOR: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACET|Quarterly EPS earnings growth celularity.com (CELU)|Year-over-year earnings per share growth for the last twelve months INmune Bio Corp INMB|Year-over-year earnings per one share growth for the last 12 months BRNS|KZR - Year-over-year earnings per share growth for the last twelve months|sabbiotherapeutics.com (SABS) - Year-over-year net earnings per share growth for the last 12 months|AKTX: Quarterly EPS earnings growth|Enlivex Therapeutics Ltd. (ENLV) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months QTTB|GOVX: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth EDSA|Year-over-year net earnings per share change for the last twelve months ibioinc.com|Year-over-year earnings per share growth for the last twelve months Carisma Therapeutics Inc. CARM|XTLB - Year-over-year net earnings per share growth for the last 12 months|BOLT - Year-over-year earnings per share growth for the last twelve months|HCW Biologics Inc. (HCWB) - Year-over-year net earnings per share growth for the last 12 months|APVO (aptevotherapeutics.com) - Year-over-year net earnings per share growth for the last 12 months|aimimmuno.com (AIM) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Aditxt Inc.|Year-over-year earnings per share growth for the last 12 months GRI (GRI Bio Inc)|Quarterly EPS earnings growth XRTX|HIND - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth REVB (Revelation Biosciences)|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months CalciMedica, Inc.|affimed.com (AFMD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ALLK|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|Year-over-year earnings per share growth for the last 12 months IGMS (IGM Bio)|Quarterly EPS earnings growth ITOS|OCEA - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth TCBP (TC BioPharm (Holdings) PLC)|THRD - Year-over-year net earnings per share growth for the last 12 months
